1 Market Overview of Depressive Disorder 1.1 Depressive Disorder Market Overview 1.1.1 Depressive Disorder Product Scope 1.1.2 Depressive Disorder Market Status and Outlook 1.2 Global Depressive Disorder Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Depressive Disorder Market Size by Region (2016-2027) 1.4 Global Depressive Disorder Historic Market Size by Region (2016-2021) 1.5 Global Depressive Disorder Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Depressive Disorder Market Size (2016-2027) 1.6.1 North America Depressive Disorder Market Size (2016-2027) 1.6.2 Europe Depressive Disorder Market Size (2016-2027) 1.6.3 Asia-Pacific Depressive Disorder Market Size (2016-2027) 1.6.4 Latin America Depressive Disorder Market Size (2016-2027) 1.6.5 Middle East & Africa Depressive Disorder Market Size (2016-2027) 2 Depressive Disorder Market Overview by Type 2.1 Global Depressive Disorder Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Depressive Disorder Historic Market Size by Type (2016-2021) 2.3 Global Depressive Disorder Forecasted Market Size by Type (2022-2027) 2.4 Tricyclic Antidepressants 2.5 Selective Serotonin Reuptake Inhibitors 2.6 Serotonin-Norepinephrine Reuptake Inhibitors 2.7 Monoamine Oxidase Inhibitors 2.8 Serotonin Antagonist And Reuptake Inhibitors 2.9 Others 3 Depressive Disorder Market Overview by Application 3.1 Global Depressive Disorder Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Depressive Disorder Historic Market Size by Application (2016-2021) 3.3 Global Depressive Disorder Forecasted Market Size by Application (2022-2027) 3.4 Hospitals 3.5 Ambulatory Surgical Centers 3.6 Diagnostic Centers 3.7 Homecare Settings 3.8 Long Term Care Centers 4 Depressive Disorder Competition Analysis by Players 4.1 Global Depressive Disorder Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Depressive Disorder as of 2020) 4.3 Date of Key Players Enter into Depressive Disorder Market 4.4 Global Top Players Depressive Disorder Headquarters and Area Served 4.5 Key Players Depressive Disorder Product Solution and Service 4.6 Competitive Status 4.6.1 Depressive Disorder Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Alkermes 5.1.1 Alkermes Profile 5.1.2 Alkermes Main Business 5.1.3 Alkermes Depressive Disorder Products, Services and Solutions 5.1.4 Alkermes Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.1.5 Alkermes Recent Developments 5.2 Allergan 5.2.1 Allergan Profile 5.2.2 Allergan Main Business 5.2.3 Allergan Depressive Disorder Products, Services and Solutions 5.2.4 Allergan Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.2.5 Allergan Recent Developments 5.3 Bristol Myers Squibb 5.3.1 Bristol Myers Squibb Profile 5.3.2 Bristol Myers Squibb Main Business 5.3.3 Bristol Myers Squibb Depressive Disorder Products, Services and Solutions 5.3.4 Bristol Myers Squibb Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.3.5 Eli Lilly Recent Developments 5.4 Eli Lilly 5.4.1 Eli Lilly Profile 5.4.2 Eli Lilly Main Business 5.4.3 Eli Lilly Depressive Disorder Products, Services and Solutions 5.4.4 Eli Lilly Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.4.5 Eli Lilly Recent Developments 5.5 Glaxosmithkline 5.5.1 Glaxosmithkline Profile 5.5.2 Glaxosmithkline Main Business 5.5.3 Glaxosmithkline Depressive Disorder Products, Services and Solutions 5.5.4 Glaxosmithkline Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.5.5 Glaxosmithkline Recent Developments 5.6 H. Lundbeck 5.6.1 H. Lundbeck Profile 5.6.2 H. Lundbeck Main Business 5.6.3 H. Lundbeck Depressive Disorder Products, Services and Solutions 5.6.4 H. Lundbeck Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.6.5 H. Lundbeck Recent Developments 5.7 Merck 5.7.1 Merck Profile 5.7.2 Merck Main Business 5.7.3 Merck Depressive Disorder Products, Services and Solutions 5.7.4 Merck Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.7.5 Merck Recent Developments 5.8 Pfizer 5.8.1 Pfizer Profile 5.8.2 Pfizer Main Business 5.8.3 Pfizer Depressive Disorder Products, Services and Solutions 5.8.4 Pfizer Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.8.5 Pfizer Recent Developments 5.9 Teva Pharmaceutical 5.9.1 Teva Pharmaceutical Profile 5.9.2 Teva Pharmaceutical Main Business 5.9.3 Teva Pharmaceutical Depressive Disorder Products, Services and Solutions 5.9.4 Teva Pharmaceutical Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.9.5 Teva Pharmaceutical Recent Developments 5.10 Takeda Pharmaceutical 5.10.1 Takeda Pharmaceutical Profile 5.10.2 Takeda Pharmaceutical Main Business 5.10.3 Takeda Pharmaceutical Depressive Disorder Products, Services and Solutions 5.10.4 Takeda Pharmaceutical Depressive Disorder Revenue (US$ Million) & (2016-2021) 5.10.5 Takeda Pharmaceutical Recent Developments 6 North America 6.1 North America Depressive Disorder Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Depressive Disorder Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Depressive Disorder Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Depressive Disorder Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Depressive Disorder Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Depressive Disorder Market Dynamics 11.1 Depressive Disorder Industry Trends 11.2 Depressive Disorder Market Drivers 11.3 Depressive Disorder Market Challenges 11.4 Depressive Disorder Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Depressive Disorder Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Depressive Disorder Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Depressive Disorder Market Size Share by Region (2016-2021) Table 4. Global Depressive Disorder Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Depressive Disorder Forecasted Market Size Share by Region (2022-2027) Table 6. Global Depressive Disorder Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Depressive Disorder Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Depressive Disorder Revenue Market Share by Type (2016-2021) Table 9. Global Depressive Disorder Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Depressive Disorder Revenue Market Share by Type (2022-2027) Table 11. Global Depressive Disorder Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Depressive Disorder Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Depressive Disorder Revenue Market Share by Application (2016-2021) Table 14. Global Depressive Disorder Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Depressive Disorder Revenue Market Share by Application (2022-2027) Table 16. Global Depressive Disorder Revenue (US$ Million) by Players (2016-2021) Table 17. Global Depressive Disorder Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Depressive Disorder as of 2020) Table 19. Date of Key Manufacturers Enter into Depressive Disorder Market Table 20. Global Depressive Disorder Top Players Headquarters and Area Served Table 21. Depressive Disorder Product Solution and Service Table 22. Global Depressive Disorder Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Alkermes Basic Information List Table 25. Alkermes Description and Business Overview Table 26. Alkermes Depressive Disorder Products, Services and Solutions Table 27. Revenue (US$ Million) in Depressive Disorder Business of Alkermes (2016-2021) Table 28. Alkermes Recent Developments Table 29. Allergan Basic Information List Table 30. Allergan Description and Business Overview Table 31. Allergan Depressive Disorder Products, Services and Solutions Table 32. Revenue (US$ Million) in Depressive Disorder Business of Allergan (2016-2021) Table 33. Allergan Recent Developments Table 34. Bristol Myers Squibb Basic Information List Table 35. Bristol Myers Squibb Description and Business Overview Table 36. Bristol Myers Squibb Depressive Disorder Products, Services and Solutions Table 37. Revenue (US$ Million) in Depressive Disorder Business of Bristol Myers Squibb (2016-2021) Table 38. Bristol Myers Squibb Recent Developments Table 39. Eli Lilly Basic Information List Table 40. Eli Lilly Description and Business Overview Table 41. Eli Lilly Depressive Disorder Products, Services and Solutions Table 42. Revenue (US$ Million) in Depressive Disorder Business of Eli Lilly (2016-2021) Table 43. Eli Lilly Recent Developments Table 44. Glaxosmithkline Basic Information List Table 45. Glaxosmithkline Description and Business Overview Table 46. Glaxosmithkline Depressive Disorder Products, Services and Solutions Table 47. Revenue (US$ Million) in Depressive Disorder Business of Glaxosmithkline (2016-2021) Table 48. Glaxosmithkline Recent Developments Table 49. H. Lundbeck Basic Information List Table 50. H. Lundbeck Description and Business Overview Table 51. H. Lundbeck Depressive Disorder Products, Services and Solutions Table 52. Revenue (US$ Million) in Depressive Disorder Business of H. Lundbeck (2016-2021) Table 53. H. Lundbeck Recent Developments Table 54. Merck Basic Information List Table 55. Merck Description and Business Overview Table 56. Merck Depressive Disorder Products, Services and Solutions Table 57. Revenue (US$ Million) in Depressive Disorder Business of Merck (2016-2021) Table 58. Merck Recent Developments Table 59. Pfizer Basic Information List Table 60. Pfizer Description and Business Overview Table 61. Pfizer Depressive Disorder Products, Services and Solutions Table 62. Revenue (US$ Million) in Depressive Disorder Business of Pfizer (2016-2021) Table 63. Pfizer Recent Developments Table 64. Teva Pharmaceutical Basic Information List Table 65. Teva Pharmaceutical Description and Business Overview Table 66. Teva Pharmaceutical Depressive Disorder Products, Services and Solutions Table 67. Revenue (US$ Million) in Depressive Disorder Business of Teva Pharmaceutical (2016-2021) Table 68. Teva Pharmaceutical Recent Developments Table 69. Takeda Pharmaceutical Basic Information List Table 70. Takeda Pharmaceutical Description and Business Overview Table 71. Takeda Pharmaceutical Depressive Disorder Products, Services and Solutions Table 72. Revenue (US$ Million) in Depressive Disorder Business of Takeda Pharmaceutical (2016-2021) Table 73. Takeda Pharmaceutical Recent Developments Table 74. North America Depressive Disorder Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Depressive Disorder Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Depressive Disorder Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Depressive Disorder Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Depressive Disorder Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Depressive Disorder Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Depressive Disorder Market Share by Region (2016-2021) Table 81. Asia-Pacific Depressive Disorder Market Share by Region (2022-2027) Table 82. Latin America Depressive Disorder Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Depressive Disorder Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Depressive Disorder Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Depressive Disorder Market Size by Country (2022-2027) & (US$ Million) Table 86. Depressive Disorder Market Trends Table 87. Depressive Disorder Market Drivers Table 88. Depressive Disorder Market Challenges Table 89. Depressive Disorder Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Depressive Disorder Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Depressive Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Depressive Disorder Market Share by Regions: 2021 VS 2027 Figure 4. Global Depressive Disorder Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Depressive Disorder Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Depressive Disorder Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Depressive Disorder Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Depressive Disorder Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Depressive Disorder Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Depressive Disorder Market Size Share by Type in 2021 & 2027 Figure 11. Tricyclic Antidepressants Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Selective Serotonin Reuptake Inhibitors Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Serotonin-Norepinephrine Reuptake Inhibitors Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Monoamine Oxidase Inhibitors Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Serotonin Antagonist And Reuptake Inhibitors Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Global Depressive Disorder Market Size Share by Application in 2021 & 2027 Figure 18. Hospitals Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Ambulatory Surgical Centers Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Diagnostic Centers Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Homecare Settings Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. Long Term Care Centers Market Size (US$ Million) YoY Growth (2016-2027) Figure 23. Depressive Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global Top 5 and Top 10 Players Depressive Disorder Market Share in 2020 Figure 25. North America Depressive Disorder Market Share by Country (2016-2027) Figure 26. United States Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 27. Canada Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 28. Germany Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 29. France Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 30. U.K. Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 31. Italy Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 32. Russia Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 33. Nordic Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 34. Rest of Europe Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Depressive Disorder Market Share by Region (2016-2027) Figure 36. China Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 37. Japan Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 38. South Korea Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 39. Southeast Asia Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 40. India Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 41. Australia Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 42. Rest of Asia-Pacific Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 43. Latin America Depressive Disorder Market Share by Country (2016-2027) Figure 44. Mexico Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 45. Brazil Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Latin America Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 47. Middle East & Africa Depressive Disorder Market Share by Country (2016-2027) Figure 48. Turkey Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 49. Saudi Arabia Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 50. UAE Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 51. Rest of Middle East & Africa Depressive Disorder Market Size (2016-2027) & (US$ Million) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation

Alkermes Allergan Bristol Myers Squibb Eli Lilly Glaxosmithkline H. Lundbeck Merck Pfizer Teva Pharmaceutical Takeda Pharmaceutical